Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/MEDOSTATIN TABLET 20 MG

Approved

THERAPEUTIC

MEDOSTATIN TABLET 20 MG

MEDOCHEMIE LTD (CYPRUS)🇸🇬 Health Sciences Authority

Approval Date: Sep 15, 1998
Approval ID: b05ee0697d6dc748
Company: MEDOCHEMIE LTD (CYPRUS)
Type: Therapeutic

Approval Details

Approval Id: b05ee0697d6dc748
Drug Name: MEDOSTATIN TABLET 20 MG
Product Name: MEDOSTATIN TABLET 20 MG
Approval Number: SIN10001P
Approval Date: 1998-09-15
Registrant: MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder: MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: C10AA02
Atc Item Name: lovastatin
Pharma Manufacturer Name: MEDOCHEMIE SINGAPORE PTE. LTD.

Active Ingredients

LOVASTATIN

20 mg

LOVASTATIN

20 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Sep 15, 1998

Approval ID

b05ee0697d6dc748

Type

Therapeutic

Back to HSA Approvals

MEDOSTATIN TABLET 20 MG - HSA Drug Approval Details